Janine Simons

[BJS @BJSurgery]

#systematicreview of targeted axillary dissection in node-positive #breastcancer treated with neoadjuvant systemic therapy: variation in type of marker and timing of placement
➡️ https://t.co/ufRez3Dz3j

In node-positive (cN+) breast cancer treated with neoadjuvant systemic therapy, combining sentinel lymph node biopsy and targeted lymph node (TLN) excision (targeted axillary dissection, TAD) increases accuracy. TAD procedures differ in terms of the TLN excision technique.
This systematic review aimed to provide an overview of TAD procedures regarding definitive marker type and timing of placement.
Owing to study heterogeneity, the optimal technique could not be determined. High-quality prospective studies reporting all relevant aspects of TAD are needed.

Great work by Sabine R de Wild, Linetta B Koppert, Thiemo J A van Nijnatten, Loes F S Kooreman, Marie-Jeanne T F D Vrancken Peeters, Marjolein L Smidt, Janine M Simons

#SoMe4Surgery #MedTwitter #SurgEd #Surgery @RCPSGTrainees @aecirujanos @SEIQuirurgica @iss_sic #MedicalTechniques @BJSAcademy @young_bjs @BJSOpen @des_winter @evanscolorectal @robhinchliffe1 @bplwijn @ksoreide @MalinASund @nfmkok @TejedorPat @paulo_sutt @PVaughanShaw @JJEarnshaw @juliomayol

[Radiotherapy & Oncology @RO_GreenJournal]

New article (Vol. 191)

Quality assurance of radiation therapy after breast-conserving surgery among patients in the BOOG 2013-08 trial
V.M. Wintraecken et al.

https://t.co/BikznrEAZ0

https://t.co/TytqniJ4eF

[Janine Simons @simons_janine]

https://t.co/fBkYBVm4FW

[Steven D Wexner MD, PhD @SWexner]

Axillary Pathologic Complete Response After Neoadjuvant Systemic Therapy by Breast Cancer Subtype https://t.co/ySYmlFldib via @JAMASurgery part of @JAMANetwork @ASBrS @ESSOnews @SocSurgOnc @ASCOPost

[Oncologie Up-to-date @OncUptodate]

Behandeling klierpositief mammacarcinoom na neoadjuvante chemotherapie. Janine Simons presenteerde resultaten tijdens het virtuele San Antonio Breast Cancer Symposium. https://t.co/H1cwwfabI3 #SABCS20 #RISAS https://t.co/9NV6VSdYV5 #mammacarcinoom #okselklierdissectie #MARI

[SABCS @SABCSSanAntonio]

The #SABCS20 Plenary Lectures are On Demand. Find the "Sessions" drop-down and that's where you'll find the On-Demand Sessions. On the mobile app, click the lines in the upper right-hand corner then open Sessions. #BCSM @MedMtgNews
https://t.co/S9tMXuWFFQ

[Janine Simons @simons_janine]

Proud and thankful that we were given the opportunity to present our results at SABCS yesterday!
#SABCS20 #TargetedAxillaryDissection

[Puneet Singh, MD FACS @puneetsinghmd]

.@simons_janine presents the Dutch RISAS trial with radioactive I-125 seed localization + SLND. Effective procedure for staging the cN+ axilla after NACT, comparable to targeted axillary dissection described by @AbigailCaudleMD #SABCS20

[Congress Care @CongressCare]

Vandaag is weer bewezen dat met een online programma vaak een groter publiek bereikt wordt dan met een live bijeenkomst. Vandaag waren ruim 350 deelnemers aanwezig bij het 11e Borstkanker Behandeling Beter congres; gestreamd vanuit @LantarenVenster, Rotterdam

[Follow the Money @FTM_nl]

Opinie | Multinationals die in goede tijden miljarden euro winst binnen harkten, willen nu in deze crisis ook gecompenseerd worden door de overheid. Dat mag, maar is dat eerlijk? https://t.co/ZUQHgfyisr

[doRadiology @doRadiology]

After nine years we can finally present the results of the @UMCUtrecht DENSE Trial on breast cancer screening with MRI in women with extremely dense breasts:https://t.co/Scaoi9cUzX

Full story: https://t.co/QtOnDXQErh

@volkskrant
https://t.co/wFJbmcXe7H

https://t.co/oHdsFRMgHG

[BJS @BJSurgery]

In the November issue of BJS: Management of the axilla after neoadjuvant chemotherapy for breast cancer https://t.co/GDjjKAINa4 @JJEarnshaw @AmyLightnerMD @bplwijn @des_winter @JohnBeynon5 @ChcDej @ksoreide @MalinASund @evanscolorectal @robhinchliffe1

[Puneet Singh, MD FACS @puneetsinghmd]

@KellyKhunt and @DrJMichaelDixon having a spirited debate on neoadjuvant endocrine therapy #ASBrS19 #bcsm @ASBrS